Timeline

Fernando Batista

Post-doc

20 Jan 2025

publication

Towards Improved Peptidic α-Ketoamide Inhibitors of the Plasmodial Subtilisin-Like SUB1: Exploration of N-Terminal Extensions and Cyclic Constraints.

05 Apr 2024

publication

Insights from structure-activity relationships and the binding mode of peptidic α-ketoamide inhibitors of the malaria drug target subtilisin-like SUB1.

15 Jul 2022

publication

Thiosulfate sulfurtransferase prevents hyperglycemic damage to the zebrafish pronephros in an experimental model for diabetes.

01 Aug 2021

publication

Clinical utility of the imunohistochemical co-expression of p53 and MDM2 in thyroid follicular lesions.

09 Sep 2020

publication

Polymorphisms of IL-4 and IL-4R are associated to some demographic characteristics of differentiated thyroid cancer patients but are not determinants of risk in the Brazilian population.

01 Jun 2020

publication

Unraveling the role of thiosulfate sulfurtransferase in metabolic diseases.

08 May 2020

publication

Molecular Target Validation of Aspartate Transcarbamoylase from Plasmodium falciparum by Torin 2.

01 Mar 2020

publication

A novel mechanism of inhibition by phenylthiourea on PvdP, a tyrosinase synthesizing pyoverdine of Pseudomonas aeruginosa.

01 Feb 2020

publication

New directions in antimalarial target validation.

28 Feb 2019

publication

Oligomeric protein interference validates druggability of aspartate interconversion in Plasmodium falciparum.

11 Mar 2018

publication

Identification of a non-competitive inhibitor of Plasmodium falciparum aspartate transcarbamoylase.

01 Feb 2018

publication

Serum interleukin measurement may help identify thyroid cancer patients with active disease.

01 Jan 2018

publication

Oligomeric interfaces as a tool in drug discovery: Specific interference with activity of malate dehydrogenase of Plasmodium falciparum in vitro.

12 Dec 2017

publication

Tyrosine kinase inhibitor sensitive PDGFRΑ mutations in GIST: Two cases and review of the literature.

01 Jan 2017

publication

Drug Target Validation Methods in Malaria – Protein Interference Assay (PIA) as a Tool for Highly Specific Drug Target Validation.

01 Jul 2016

publication

Crystal structure of truncated aspartate transcarbamoylase from Plasmodium falciparum.

01 Apr 2016

publication

Gene expression of thyroid-specific transcription factors may help diagnose thyroid lesions but are not determinants of tumor progression.

01 Feb 2016

team

Trypanosome Molecular Biology

01 Oct 2014

publication

Obesity and thyroid cancer.

01 Jan 2014

publication

A little guide for advanced search:

Timeline

Towards Improved Peptidic α-Ketoamide Inhibitors of the Plasmodial Subtilisin-Like SUB1: Exploration of N-Terminal Extensions and Cyclic Constraints.

Insights from structure-activity relationships and the binding mode of peptidic α-ketoamide inhibitors of the malaria drug target subtilisin-like SUB1.

Thiosulfate sulfurtransferase prevents hyperglycemic damage to the zebrafish pronephros in an experimental model for diabetes.

Clinical utility of the imunohistochemical co-expression of p53 and MDM2 in thyroid follicular lesions.

Polymorphisms of IL-4 and IL-4R are associated to some demographic characteristics of differentiated thyroid cancer patients but are not determinants of risk in the Brazilian population.

Unraveling the role of thiosulfate sulfurtransferase in metabolic diseases.

Molecular Target Validation of Aspartate Transcarbamoylase from Plasmodium falciparum by Torin 2.

A novel mechanism of inhibition by phenylthiourea on PvdP, a tyrosinase synthesizing pyoverdine of Pseudomonas aeruginosa.

New directions in antimalarial target validation.

Oligomeric protein interference validates druggability of aspartate interconversion in Plasmodium falciparum.

Identification of a non-competitive inhibitor of Plasmodium falciparum aspartate transcarbamoylase.

Serum interleukin measurement may help identify thyroid cancer patients with active disease.

Oligomeric interfaces as a tool in drug discovery: Specific interference with activity of malate dehydrogenase of Plasmodium falciparum in vitro.

Tyrosine kinase inhibitor sensitive PDGFRΑ mutations in GIST: Two cases and review of the literature.

Drug Target Validation Methods in Malaria – Protein Interference Assay (PIA) as a Tool for Highly Specific Drug Target Validation.

Crystal structure of truncated aspartate transcarbamoylase from Plasmodium falciparum.

Gene expression of thyroid-specific transcription factors may help diagnose thyroid lesions but are not determinants of tumor progression.

Trypanosome Molecular Biology

Obesity and thyroid cancer.

CD8+ TIL recruitment may revert the association of MAGE A3 with aggressive features in thyroid tumors.